Update on Hepatitis B Management: CME/CE-Certified Expert Analysis From EASL

[Guest guest]

> *CCO is an independent medical education company that provides

state-of-the-art medical information to healthcare professionals through

conference coverage and other educational programs.

>

> CME/CE-Certified Expert Analysis

> Click to Access

> Update on Hepatitis B Management

> CCO Independent Conference Coverage of the

> 2008 Annual Meeting of the European Association for the Study of the Liver*

>

> Dear colleague,

>

> Following the EASL meeting in Milan, Italy, Kris V. Kowdley, MD, FACP, FACG,

FASGE, AGAF; Norah Terrault, MD, MPH; and I met for an engaging conversation

about the new data presented on the management of hepatitis B. I am pleased to

share these data with you in a CME/CE-certified Expert Analysis on the Clinical

Care Options Web site.

>

> Topics we discussed include:

>

> * Peginterferon alfa-2a in HBeAg-Negative Chronic Hepatitis B

> * Predicting Responses to Peginterferon alfa-2a

> * Tenofovir vs Adefovir in Chronic Hepatitis B

> * Long-term Efficacy of Entecavir

> * Durability of HBeAg Seroconversion With Telbivudine or Lamivudine

> * Tenofovir-Based Regimens in Nucleos(t)ide-Experienced and

Nucleos(t)ide-Refractory Patients

> * Adefovir Plus Lamivudine in Lamivudine-Resistant HBV

> * Long-term Entecavir in Chinese Patients With Lamivudine-Refractory HBV

> * Preexisting Resistance Mutations in Treatment-Naive Patients

>

> To read our Expert Analysis, click here.

>

> I am confident that you will find data important to your practice.

>

> Regards,

>

> [http://clinicaloptions.com/upload/global/headshots/marcellin_patrick.jpg]

>

> Marcellin, MD

> Professor of Medicine

> Service d'Hepatologie

> INSERM CRB3

> Hôpital Beaujon

> University of Paris

> Clichy, France

>

>

> This Expert Analysis is located online at:

> http://clinicaloptions.com/Hepatitis/Conference%20Coverage/Milan%202008.aspx

>

>

>

> [http://images.clinicaloptions.com/img.asp?img=/logo/pim.gif]

>

> [http://images.clinicaloptions.com/img.asp?img=/cco/CCO_hep_logo.jpg]

>

> Physicians:

> Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care

Options, LLC.

>

> Nurses:

> Nursing contact hours provided through the cosponsorship of Postgraduate

Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute

for Medicine is accredited as a provider of continuing nursing education by the

American Nurses Credentialing Center's Commission on Accreditation.

>

> Pharmacists:

> Postgraduate Institute for Medicine is accredited by the Accreditation Council

for Pharmacy Education as a provider of continuing pharmacy education. Pharmacy

credit hours provided through the cosponsorship of Postgraduate Institute for

Medicine and Clinical Care Options, LLC.

>

> [http://clinicaloptions.com/assets/bin/logo/acpe-50.jpg]

>

> Release date: July 3, 2008

> Expiration date: July 2, 2009

>

> Supported by educational grants from Bristol-Myers Squibb; Gilead Sciences;

Pharmasset, Inc.;

> Tibotec, a Division of Janssen-Cilag; and Vertex.

>

>

[http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/Bristol-MyersSqui\

bb.gif]

>

>

>

[http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/Gileadwithtagline\

..gif]

>

>

> [http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/pharmasset.gif]

>

>

>

>

>

[http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/tibotec_janssen.g\

if]

>

>

> [http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/Vertex.gif]

>

>

>

>

>

>

[http://images.clinicaloptions.com/img.asp?img=/House/Hep/Bookstore_Hep_00g.gif]

>

> Unsubscribe | Not a member yet? Click here | RSS | Hepatitis Podcasts |

Bookstore

>

> To ensure you receive Clinical Care Options educational materials by email,

> please add info@... to your contacts or address book.

>

> Copyright 2008 Clinical Care Options, LLC. All rights reserved. 1894 Preston

White Drive, Suite 110, Reston, VA 20191-5433

_________________________________________________________________

Stay in touch when you're away with Windows Live Messenger.

http://www.windowslive.com/messenger/overview.html?ocid=TXT_TAGLM_WL_messenger2_\

072008

[Guest guest]

> *CCO is an independent medical education company that provides

state-of-the-art medical information to healthcare professionals through

conference coverage and other educational programs.

>

> CME/CE-Certified Expert Analysis

> Click to Access

> Update on Hepatitis B Management

> CCO Independent Conference Coverage of the

> 2008 Annual Meeting of the European Association for the Study of the Liver*

>

> Dear colleague,

>

> Following the EASL meeting in Milan, Italy, Kris V. Kowdley, MD, FACP, FACG,

FASGE, AGAF; Norah Terrault, MD, MPH; and I met for an engaging conversation

about the new data presented on the management of hepatitis B. I am pleased to

share these data with you in a CME/CE-certified Expert Analysis on the Clinical

Care Options Web site.

>

> Topics we discussed include:

>

> * Peginterferon alfa-2a in HBeAg-Negative Chronic Hepatitis B

> * Predicting Responses to Peginterferon alfa-2a

> * Tenofovir vs Adefovir in Chronic Hepatitis B

> * Long-term Efficacy of Entecavir

> * Durability of HBeAg Seroconversion With Telbivudine or Lamivudine

> * Tenofovir-Based Regimens in Nucleos(t)ide-Experienced and

Nucleos(t)ide-Refractory Patients

> * Adefovir Plus Lamivudine in Lamivudine-Resistant HBV

> * Long-term Entecavir in Chinese Patients With Lamivudine-Refractory HBV

> * Preexisting Resistance Mutations in Treatment-Naive Patients

>

> To read our Expert Analysis, click here.

>

> I am confident that you will find data important to your practice.

>

> Regards,

>

> [http://clinicaloptions.com/upload/global/headshots/marcellin_patrick.jpg]

>

> Marcellin, MD

> Professor of Medicine

> Service d'Hepatologie

> INSERM CRB3

> Hôpital Beaujon

> University of Paris

> Clichy, France

>

>

> This Expert Analysis is located online at:

> http://clinicaloptions.com/Hepatitis/Conference%20Coverage/Milan%202008.aspx

>

>

>

> [http://images.clinicaloptions.com/img.asp?img=/logo/pim.gif]

>

> [http://images.clinicaloptions.com/img.asp?img=/cco/CCO_hep_logo.jpg]

>

> Physicians:

> Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care

Options, LLC.

>

> Nurses:

> Nursing contact hours provided through the cosponsorship of Postgraduate

Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute

for Medicine is accredited as a provider of continuing nursing education by the

American Nurses Credentialing Center's Commission on Accreditation.

>

> Pharmacists:

> Postgraduate Institute for Medicine is accredited by the Accreditation Council

for Pharmacy Education as a provider of continuing pharmacy education. Pharmacy

credit hours provided through the cosponsorship of Postgraduate Institute for

Medicine and Clinical Care Options, LLC.

>

> [http://clinicaloptions.com/assets/bin/logo/acpe-50.jpg]

>

> Release date: July 3, 2008

> Expiration date: July 2, 2009

>

> Supported by educational grants from Bristol-Myers Squibb; Gilead Sciences;

Pharmasset, Inc.;

> Tibotec, a Division of Janssen-Cilag; and Vertex.

>

>

[http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/Bristol-MyersSqui\

bb.gif]

>

>

>

[http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/Gileadwithtagline\

..gif]

>

>

> [http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/pharmasset.gif]

>

>

>

>

>

[http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/tibotec_janssen.g\

if]

>

>

> [http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/Vertex.gif]

>

>

>

>

>

>

[http://images.clinicaloptions.com/img.asp?img=/House/Hep/Bookstore_Hep_00g.gif]

>

> Unsubscribe | Not a member yet? Click here | RSS | Hepatitis Podcasts |

Bookstore

>

> To ensure you receive Clinical Care Options educational materials by email,

> please add info@... to your contacts or address book.

>

> Copyright 2008 Clinical Care Options, LLC. All rights reserved. 1894 Preston

White Drive, Suite 110, Reston, VA 20191-5433

_________________________________________________________________

Stay in touch when you're away with Windows Live Messenger.

http://www.windowslive.com/messenger/overview.html?ocid=TXT_TAGLM_WL_messenger2_\

072008

[Guest guest]

> *CCO is an independent medical education company that provides

state-of-the-art medical information to healthcare professionals through

conference coverage and other educational programs.

>

> CME/CE-Certified Expert Analysis

> Click to Access

> Update on Hepatitis B Management

> CCO Independent Conference Coverage of the

> 2008 Annual Meeting of the European Association for the Study of the Liver*

>

> Dear colleague,

>

> Following the EASL meeting in Milan, Italy, Kris V. Kowdley, MD, FACP, FACG,

FASGE, AGAF; Norah Terrault, MD, MPH; and I met for an engaging conversation

about the new data presented on the management of hepatitis B. I am pleased to

share these data with you in a CME/CE-certified Expert Analysis on the Clinical

Care Options Web site.

>

> Topics we discussed include:

>

> * Peginterferon alfa-2a in HBeAg-Negative Chronic Hepatitis B

> * Predicting Responses to Peginterferon alfa-2a

> * Tenofovir vs Adefovir in Chronic Hepatitis B

> * Long-term Efficacy of Entecavir

> * Durability of HBeAg Seroconversion With Telbivudine or Lamivudine

> * Tenofovir-Based Regimens in Nucleos(t)ide-Experienced and

Nucleos(t)ide-Refractory Patients

> * Adefovir Plus Lamivudine in Lamivudine-Resistant HBV

> * Long-term Entecavir in Chinese Patients With Lamivudine-Refractory HBV

> * Preexisting Resistance Mutations in Treatment-Naive Patients

>

> To read our Expert Analysis, click here.

>

> I am confident that you will find data important to your practice.

>

> Regards,

>

> [http://clinicaloptions.com/upload/global/headshots/marcellin_patrick.jpg]

>

> Marcellin, MD

> Professor of Medicine

> Service d'Hepatologie

> INSERM CRB3

> Hôpital Beaujon

> University of Paris

> Clichy, France

>

>

> This Expert Analysis is located online at:

> http://clinicaloptions.com/Hepatitis/Conference%20Coverage/Milan%202008.aspx

>

>

>

> [http://images.clinicaloptions.com/img.asp?img=/logo/pim.gif]

>

> [http://images.clinicaloptions.com/img.asp?img=/cco/CCO_hep_logo.jpg]

>

> Physicians:

> Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care

Options, LLC.

>

> Nurses:

> Nursing contact hours provided through the cosponsorship of Postgraduate

Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute

for Medicine is accredited as a provider of continuing nursing education by the

American Nurses Credentialing Center's Commission on Accreditation.

>

> Pharmacists:

> Postgraduate Institute for Medicine is accredited by the Accreditation Council

for Pharmacy Education as a provider of continuing pharmacy education. Pharmacy

credit hours provided through the cosponsorship of Postgraduate Institute for

Medicine and Clinical Care Options, LLC.

>

> [http://clinicaloptions.com/assets/bin/logo/acpe-50.jpg]

>

> Release date: July 3, 2008

> Expiration date: July 2, 2009

>

> Supported by educational grants from Bristol-Myers Squibb; Gilead Sciences;

Pharmasset, Inc.;

> Tibotec, a Division of Janssen-Cilag; and Vertex.

>

>

[http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/Bristol-MyersSqui\

bb.gif]

>

>

>

[http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/Gileadwithtagline\

..gif]

>

>

> [http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/pharmasset.gif]

>

>

>

>

>

[http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/tibotec_janssen.g\

if]

>

>

> [http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/Vertex.gif]

>

>

>

>

>

>

[http://images.clinicaloptions.com/img.asp?img=/House/Hep/Bookstore_Hep_00g.gif]

>

> Unsubscribe | Not a member yet? Click here | RSS | Hepatitis Podcasts |

Bookstore

>

> To ensure you receive Clinical Care Options educational materials by email,

> please add info@... to your contacts or address book.

>

> Copyright 2008 Clinical Care Options, LLC. All rights reserved. 1894 Preston

White Drive, Suite 110, Reston, VA 20191-5433

_________________________________________________________________

Stay in touch when you're away with Windows Live Messenger.

http://www.windowslive.com/messenger/overview.html?ocid=TXT_TAGLM_WL_messenger2_\

072008

[Guest guest]

> *CCO is an independent medical education company that provides

state-of-the-art medical information to healthcare professionals through

conference coverage and other educational programs.

>

> CME/CE-Certified Expert Analysis

> Click to Access

> Update on Hepatitis B Management

> CCO Independent Conference Coverage of the

> 2008 Annual Meeting of the European Association for the Study of the Liver*

>

> Dear colleague,

>

> Following the EASL meeting in Milan, Italy, Kris V. Kowdley, MD, FACP, FACG,

FASGE, AGAF; Norah Terrault, MD, MPH; and I met for an engaging conversation

about the new data presented on the management of hepatitis B. I am pleased to

share these data with you in a CME/CE-certified Expert Analysis on the Clinical

Care Options Web site.

>

> Topics we discussed include:

>

> * Peginterferon alfa-2a in HBeAg-Negative Chronic Hepatitis B

> * Predicting Responses to Peginterferon alfa-2a

> * Tenofovir vs Adefovir in Chronic Hepatitis B

> * Long-term Efficacy of Entecavir

> * Durability of HBeAg Seroconversion With Telbivudine or Lamivudine

> * Tenofovir-Based Regimens in Nucleos(t)ide-Experienced and

Nucleos(t)ide-Refractory Patients

> * Adefovir Plus Lamivudine in Lamivudine-Resistant HBV

> * Long-term Entecavir in Chinese Patients With Lamivudine-Refractory HBV

> * Preexisting Resistance Mutations in Treatment-Naive Patients

>

> To read our Expert Analysis, click here.

>

> I am confident that you will find data important to your practice.

>

> Regards,

>

> [http://clinicaloptions.com/upload/global/headshots/marcellin_patrick.jpg]

>

> Marcellin, MD

> Professor of Medicine

> Service d'Hepatologie

> INSERM CRB3

> Hôpital Beaujon

> University of Paris

> Clichy, France

>

>

> This Expert Analysis is located online at:

> http://clinicaloptions.com/Hepatitis/Conference%20Coverage/Milan%202008.aspx

>

>

>

> [http://images.clinicaloptions.com/img.asp?img=/logo/pim.gif]

>

> [http://images.clinicaloptions.com/img.asp?img=/cco/CCO_hep_logo.jpg]

>

> Physicians:

> Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care

Options, LLC.

>

> Nurses:

> Nursing contact hours provided through the cosponsorship of Postgraduate

Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute

for Medicine is accredited as a provider of continuing nursing education by the

American Nurses Credentialing Center's Commission on Accreditation.

>

> Pharmacists:

> Postgraduate Institute for Medicine is accredited by the Accreditation Council

for Pharmacy Education as a provider of continuing pharmacy education. Pharmacy

credit hours provided through the cosponsorship of Postgraduate Institute for

Medicine and Clinical Care Options, LLC.

>

> [http://clinicaloptions.com/assets/bin/logo/acpe-50.jpg]

>

> Release date: July 3, 2008

> Expiration date: July 2, 2009

>

> Supported by educational grants from Bristol-Myers Squibb; Gilead Sciences;

Pharmasset, Inc.;

> Tibotec, a Division of Janssen-Cilag; and Vertex.

>

>

[http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/Bristol-MyersSqui\

bb.gif]

>

>

>

[http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/Gileadwithtagline\

..gif]

>

>

> [http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/pharmasset.gif]

>

>

>

>

>

[http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/tibotec_janssen.g\

if]

>

>

> [http://images.clinicaloptions.com/img.asp?img=/logo/new_logos/Vertex.gif]

>

>

>

>

>

>

[http://images.clinicaloptions.com/img.asp?img=/House/Hep/Bookstore_Hep_00g.gif]

>

> Unsubscribe | Not a member yet? Click here | RSS | Hepatitis Podcasts |

Bookstore

>

> To ensure you receive Clinical Care Options educational materials by email,

> please add info@... to your contacts or address book.

>

> Copyright 2008 Clinical Care Options, LLC. All rights reserved. 1894 Preston

White Drive, Suite 110, Reston, VA 20191-5433

_________________________________________________________________

Stay in touch when you're away with Windows Live Messenger.

http://www.windowslive.com/messenger/overview.html?ocid=TXT_TAGLM_WL_messenger2_\

072008